Botulinum Toxin Type A
Contracture of the joint in Multiple Sclerosis
All brands within licensed indications only
NICE CG186 does not make a recommendation on use of botulinum toxin A for contracture of the joint in MS and states that problems are ‘complex and need individual assessment. Botulinum injection along with prolonged stretching modalities using serial plaster casts, standing frames or removable splints, has been approved locally after a review of audit data, provided
treatment is restricted to those patients who have failed or could not have other treatments
treatment is only initiated by an appropriate specialist with experience in use of botulinum toxin A, that there are clearly defined goals of treatment — set prior to initiation and against which patients will be reviewed at each injection cycle.